Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 1/20 | 0.31 |
| ▸ | MAOB | P27338 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6706818 | 0.73 | KMT2A (0.47) | CYP3A4 | |
| SCHEMBL28002894 | 0.69 | LMNA (0.41) | CYP3A4 | |
| SCHEMBL24576653 | 0.69 | AKT1 (0.32) | CYP3A4 | |
| SCHEMBL5965069 | 0.69 | MAOA (0.44) | MAOAMAOB | |
| SCHEMBL19151252 | 0.69 | ALDH1A1 (0.46) | CYP3A4 | |
| SCHEMBL27892644 | 0.68 | PNMT (0.39) | MAOAMAOBCYP3A4 | |
| SCHEMBL536538 | 0.68 | GABRA1 (0.40) | CYP3A4 | |
| SCHEMBL19041360 | 0.68 | TSHR (0.31) | MAOAMAOB | |
| SCHEMBL17963823 | 0.67 | TRPA1 (0.39) | CYP3A4 | |
| SCHEMBL17963820 | 0.67 | TRPA1 (0.39) | CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200199154-A1 | COMPOUNDS FOR ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2020-06-25 | — | — | US | disclosed |
| US-10446759-B2 | Phenanthrene compounds for organic electronic devices | MERCK PATENT GMBH (DE) | 2019-10-15 | — | — | US | disclosed |
| US-9978950-B2 | Materials for electronic devices | MERCK PATENT GMBH (DE) | 2018-05-22 | — | — | US | disclosed |
| US-20180102479-A1 | PHENANTHRENE COMPOUNDS FOR ORGANIC ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2018-04-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10446759-B2 | Phenanthrene compounds for organic electronic devices | PAH, CYP1A1, AHR | MAOA 422/4885MAOB 640/4885CYP3A4 22/4885 |
| US-20200199154-A1 | COMPOUNDS FOR ELECTRONIC DEVICES | DDT, CYP2C9, CYP2D6 | MAOA 103/4885MAOB 41/4885CYP3A4 40/4885 |
| US-20180102479-A1 | PHENANTHRENE COMPOUNDS FOR ORGANIC ELECTRONIC DEVICES | PAH, CYP1A1, AHR | MAOA 422/4885MAOB 640/4885CYP3A4 22/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.